Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Juno Therapeutics, Inc. (JUNO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/07/2018 |
4
| Wilderotter Mary Agnes (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Disposed/sold 75,000 options to buy
@ $8.72, valued at
$654k
Disposed/sold 12,000 options to buy
@ $60, valued at
$720k
Disposed/sold 12,000 options to buy
@ $42.4, valued at
$508.8k
Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
| 03/07/2018 |
4
| PIEN HOWARD H (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Gifted 12,251 shares
@ $0
Gifted 1,162 shares
@ $0
Unknown transaction of 111,587 shares
@ $87, valued at
$9.7M
Disposed/sold 5,050 shares
@ $87, valued at
$439.4k
Disposed/sold 12,000 options to buy
@ $60, valued at
$720k
Disposed/sold 12,000 options to buy
@ $42.4, valued at
$508.8k
Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
| 03/07/2018 |
4
| NELSEN ROBERT (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Unknown transaction of 50,824 shares
@ $87, valued at
$4.4M
Disposed/sold 3,234 shares
@ $87, valued at
$281.4k
Unknown transaction of 10,552,390 shares
@ $87, valued at
$918.1M
Disposed/sold 12,000 options to buy
@ $60, valued at
$720k
Disposed/sold 12,000 options to buy
@ $42.4, valued at
$508.8k
Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
| 03/07/2018 |
4
| LEE ANN L. (EVP, Technical Operations) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Disposed/sold 35,004 shares
@ $0
Disposed/sold 40,788 shares
@ $0
Disposed/sold 35,000 shares
@ $0
Disposed/sold 152,900 options to buy
@ $62.85, valued at
$9.6M
|
|
| 03/07/2018 |
4
| Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Gifted 23,250 shares
@ $0
Unknown transaction of 705,525 shares
@ $87, valued at
$61.4M
Disposed/sold 12,000 options to buy
@ $60, valued at
$720k
Disposed/sold 12,000 options to buy
@ $42.4, valued at
$508.8k
Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
| 03/07/2018 |
4
| Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Unknown transaction of 492,355 shares
@ $87, valued at
$42.8M
Disposed/sold 50,010 shares
@ $87, valued at
$4.4M
Disposed/sold 20,580 shares
@ $0
Disposed/sold 29,135 shares
@ $0
Disposed/sold 11,544 shares
@ $0
Disposed/sold 35,893 shares
@ $0
Disposed/sold 98,750 options to buy
@ $8.72, valued at
$861.1k
Disposed/sold 85,000 options to buy
@ $48.06, valued at
$4.1M
Disposed/sold 155,000 options to buy
@ $24.5, valued at
$3.8M
Disposed/sold 127,841 options to buy
@ $20.76, valued at
$2.7M
|
|
| 03/07/2018 |
4
| FLATLEY JAY T (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Unknown transaction of 31,500 shares
@ $87, valued at
$2.7M
Disposed/sold 18,000 options to buy
@ $24.07, valued at
$433.3k
Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
| 03/07/2018 |
4
| EVNIN ANTHONY B (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Gifted 25,000 shares
@ $0
Gifted 34,842 shares
@ $0
Disposed/sold 12,000 options to buy
@ $60, valued at
$720k
Disposed/sold 12,000 options to buy
@ $42.4, valued at
$508.8k
Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
| 03/07/2018 |
4
| Daniel Thomas O (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
| 03/07/2018 |
4
| Cassidy Bernard J (General Counsel & Secretary) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Unknown transaction of 5,558 shares
@ $87, valued at
$483.5k
Disposed/sold 18,293 shares
@ $0
Disposed/sold 25,639 shares
@ $0
Disposed/sold 35,893 shares
@ $0
Unknown transaction of 26,869 shares
@ $87, valued at
$2.3M
Disposed/sold 125,000 options to buy
@ $6.36, valued at
$795k
Disposed/sold 37,500 options to buy
@ $8.72, valued at
$327k
Disposed/sold 50,500 options to buy
@ $48.06, valued at
$2.4M
Disposed/sold 75,000 options to buy
@ $24.5, valued at
$1.8M
Disposed/sold 113,636 options to buy
@ $20.76, valued at
$2.4M
|
|
| 03/07/2018 |
4
| Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Unknown transaction of 2,263,948 shares
@ $87, valued at
$197M
Disposed/sold 48,829 shares
@ $87, valued at
$4.2M
Disposed/sold 33,133 shares
@ $0
Disposed/sold 66,426 shares
@ $0
Disposed/sold 35,893 shares
@ $0
Disposed/sold 451,756 options to buy
@ $6.36, valued at
$2.9M
Disposed/sold 140,000 options to buy
@ $48.06, valued at
$6.7M
Disposed/sold 200,000 options to buy
@ $24.5, valued at
$4.9M
Disposed/sold 205,823 options to buy
@ $20.76, valued at
$4.3M
|
|
| 03/07/2018 |
4
| Barron Hal (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Unknown transaction of 100,000 shares
@ $87, valued at
$8.7M
Disposed/sold 3,780 shares
@ $87, valued at
$328.9k
Disposed/sold 75,000 options to buy
@ $6.36, valued at
$477k
Disposed/sold 12,000 options to buy
@ $60, valued at
$720k
Disposed/sold 12,000 options to buy
@ $42.4, valued at
$508.8k
Disposed/sold 12,000 options to buy
@ $23.29, valued at
$279.5k
|
|
| 03/07/2018 |
4
| Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Disposed/sold 7,500 shares
@ $0
Disposed/sold 20,580 shares
@ $0
Disposed/sold 25,639 shares
@ $0
Disposed/sold 35,893 shares
@ $0
Disposed/sold 93,294 options to buy
@ $51.76, valued at
$4.8M
Disposed/sold 30,002 options to buy
@ $25.29, valued at
$758.8k
Disposed/sold 98,545 options to buy
@ $20.76, valued at
$2M
|
|
| 03/07/2018 |
4
| AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Disposed/sold 84,549 shares
@ $0
Disposed/sold 29,135 shares
@ $0
Disposed/sold 35,893 shares
@ $0
Disposed/sold 313,797 options to buy
@ $24.01, valued at
$7.5M
|
|
| 03/06/2018 |
3
| CELGENE CORP /DE/ (10% Owner) has filed a Form 3 on Juno Therapeutics, Inc. |
| 03/01/2018 |
4
| Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 11,544 shares
@ $0 |
|
| 02/15/2018 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/14/2018 |
4
| Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Sold 4,157 shares
@ $85.55, valued at
$355.6k
|
|
| 02/09/2018 |
4
| Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,704 shares
@ $85.49, valued at
$145.7k
Gifted 162,790 shares
@ $0 |
|
| 02/09/2018 |
4
| Cassidy Bernard J (General Counsel & Secretary) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,528 shares
@ $85.49, valued at
$130.6k
Gifted 26,634 shares
@ $0 |
|
| 02/09/2018 |
4
| Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,346 shares
@ $85.49, valued at
$371.5k
Gifted 116,280 shares
@ $0 |
|
| 02/09/2018 |
4
| Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,700 shares
@ $85.49, valued at
$230.8k
Sold 3,497 shares
@ $85.77, valued at
$299.9k
Exercised 834 options to buy
@ $25.29, valued at
$21.1k
Exercised 2,663 options to buy
@ $20.76, valued at
$55.3k
|
|
| 02/02/2018 |
4
| LEE ANN L. (EVP, Technical Operations) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 40,788 shares
@ $0 |
|
| 02/02/2018 |
4
| Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 29,135 shares
@ $0 |
|
| 02/02/2018 |
4
| Cassidy Bernard J (General Counsel & Secretary) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 25,639 shares
@ $0 |
|
| 02/02/2018 |
4
| Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 66,426 shares
@ $0 |
|
| 02/02/2018 |
4
| Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 25,639 shares
@ $0
Sold 4,167 shares
@ $85.78, valued at
$357.4k
Exercised 4,167 options to buy
@ $51.76, valued at
$215.7k
|
|
| 02/02/2018 |
4
| AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 29,135 shares
@ $0 |
|
| 01/30/2018 |
4
| FLATLEY JAY T (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $22.92, valued at
$229.2k
|
|
| 01/24/2018 |
4
| Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Sold 102,539 shares
@ $86.25, valued at
$8.8M
Exercised 102,539 options to buy
@ $51.76, valued at
$5.3M
|
|
| 01/19/2018 |
4
| Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Sold 21,141 shares
@ $68.1, valued at
$1.4M
Sold 7,990 shares
@ $69.95, valued at
$558.9k
Exercised 2,498 options to buy
@ $25.29, valued at
$63.2k
Exercised 26,633 options to buy
@ $20.76, valued at
$552.9k
|
|
| 01/18/2018 |
4
| Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Sold 65,820 shares
@ $44.7163, valued at
$2.9M
Sold 89,888 shares
@ $45.5321, valued at
$4.1M
Sold 49,082 shares
@ $46.5247, valued at
$2.3M
Sold 23,003 shares
@ $47.6925, valued at
$1.1M
Sold 42,457 shares
@ $48.5648, valued at
$2.1M
Exercised 245,750 options to buy
@ $6.36, valued at
$1.6M
|
|
| 01/09/2018 |
4
| PIEN HOWARD H (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Gifted 25,000 shares
@ $0
Granted 417 shares
@ $0 |
|
| 01/09/2018 |
4
| NELSEN ROBERT (Director) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 237 shares
@ $0 |
|
|
|
|